doi: 10.3390/antiox11040745 223 CuttingEHortaFDangVVan RumsteMMMolBWJ
Look for platforms that clearly outline their fees, including consultation costs, medication prices, and any ongoing charges
Preliminary evidence suggests that use of GLP-1 agonists such semaglutide or GLP-1 dual agonists such as tirzepatide to treat type 2 diabetes or for weight loss do not increase the risk of breast cancer
Our protocols are thoughtfully designed, medically appropriate, and tailored to each individualbecause safety, precision, and personalization matter
Each batch is rigorously third-party tested in FDA- and DEA-registered labs
Our programmes are designed to meet people where they are, whether that means support with weight loss through compassionate one-to-one health coaching, or access to the latest weight-loss medications (like Mounjaro and Wegovy) delivered alongside expert care from a multidisciplinary team of doctors, psychologists, dietitians, and personal trainers